We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $42.5B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+0.33%
1 Year Est. Return
+18.19%
3 Year Est. Return
+63.85%
5 Year Est. Return
+89.78%
10 Year Est. Return
+309.54%
AUM
$40.2B
AUM Growth
-$933M
Cap. Flow
-$563M
Cap. Flow %
-1.4%
Top 10 Hldgs %
41.26%
Holding
326
New
14
Increased
66
Reduced
135
Closed
15

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$382M
2
ETN icon
Eaton
ETN
+$274M
3
NVDA icon
NVIDIA
NVDA
+$110M
4
LLY icon
Eli Lilly
LLY
+$40.2M
5
NOW icon
ServiceNow
NOW
+$32.3M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$194M
2
UNP icon
Union Pacific
UNP
+$185M
3
AZN icon
AstraZeneca
AZN
+$164M
4
MSFT icon
Microsoft
MSFT
+$81.1M
5
V icon
Visa
V
+$76.3M

Sector Composition

Rank Sector Weight
1 Technology 27.83%
2 Financials 19.19%
3 Consumer Staples 12.47%
4 Healthcare 10.91%
5 Energy 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TROW icon
26
T. Rowe Price
TROW
$22.6B
$516M 1.28%
5,615,761
-436,708
-7% -$46.1M
UNP icon
27
Union Pacific
UNP
$169B
$500M 1.24%
2,105,657
-769,833
-27% -$185M
ASML icon
28
ASML
ASML
$605B
$471M 1.17%
710,668
+18,516
+3% +$13.5M
ABBV icon
29
AbbVie
ABBV
$463B
$454M 1.13%
2,166,269
-39,919
-2% -$7.76M
PEP icon
30
PepsiCo
PEP
$186B
$439M 1.09%
2,914,132
-71,809
-2% -$10.7M
ADP icon
31
Automatic Data Processing
ADP
$110B
$414M 1.03%
1,353,567
-4,691
-0.3% -$1.41M
BRK.B icon
32
Berkshire Hathaway Class B
BRK.B
$1.1T
$379M 0.94%
711,923
-12,397
-2% -$6.03M
LLY icon
33
Eli Lilly
LLY
$1.01T
$366M 0.91%
443,587
+48,290
+12% +$40.2M
ICE icon
34
Intercontinental Exchange
ICE
$88.6B
$366M 0.91%
2,120,738
-42,314
-2% -$6.93M
CB icon
35
Chubb
CB
$132B
$363M 0.9%
1,202,282
-53,816
-4% -$15M
MO icon
36
Altria Group
MO
$118B
$344M 0.85%
5,726,929
-313,321
-5% -$17.1M
CP icon
37
Canadian Pacific Kansas City
CP
$78.9B
$341M 0.85%
4,789,114
+9,171
+0.2% +$698K
TSM icon
38
TSMC
TSM
$2.17T
$339M 0.84%
2,011,742
+69,922
+4% +$13.6M
CME icon
39
CME Group
CME
$101B
$337M 0.84%
1,270,882
-252,554
-17% -$62.3M
BRK.A icon
40
Berkshire Hathaway Class A
BRK.A
$1.1T
$315M 0.78%
395
-11
-3% -$8.02M
ETN icon
41
Eaton
ETN
$153B
$282M 0.7%
1,025,903
+880,656
+606% +$274M
MDLZ icon
42
Mondelez International
MDLZ
$79.6B
$279M 0.69%
4,114,063
-405,632
-9% -$25M
AZN icon
43
AstraZeneca
AZN
$254B
$272M 0.68%
684,935
-1,136,570
-62% -$164M
NOW icon
44
ServiceNow
NOW
$147B
$271M 0.67%
1,685,570
+167,440
+11% +$32.3M
MRK icon
45
Merck
MRK
$357B
$262M 0.65%
2,917,391
-287,516
-9% -$26.8M
MAR icon
46
Marriott International
MAR
$88.8B
$244M 0.61%
1,010,867
-36,289
-3% -$9.86M
ADBE icon
47
Adobe
ADBE
$106B
$243M 0.6%
626,934
+4,411
+0.7% +$1.89M
HD icon
48
Home Depot
HD
$310B
$241M 0.6%
657,798
+26,317
+4% +$10.3M
SHW icon
49
Sherwin-Williams
SHW
$78.8B
$241M 0.6%
689,294
-8,194
-1% -$2.88M
MS icon
50
Morgan Stanley
MS
$324B
$237M 0.59%
2,030,443
-208,271
-9% -$26.8M
1
2
3 4 5

Similar funds

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
GAM
Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $41.9B AUM 18.91% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $41.5B AUM 16.76% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Fayez Sarofim & Co's Q1 2025 Portfolio in Review

As of Q1 2025, Fayez Sarofim & Co held 326 positions worth $40.2B, down 2.3% from $41.1B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Fayez Sarofim & Co's Q1 2025 filing shows 14 new, 66 increased, 135 reduced and 15 closed positions. Its largest new stake was BNY Mellon Concentrated Growth ETF: 191,899 shares worth $0. The largest sale was UnitedHealth, an estimated $194M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Financials and Consumer Staples.

  • Fayez Sarofim & Co's largest Q1 2025 buy was BNY Mellon Concentrated Growth ETF: 191,899 shares worth $0.
  • Fayez Sarofim & Co added most to Meta Platforms (Facebook) in Q1 2025, an estimated $382M increase.
  • Fayez Sarofim & Co's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $194M.
  • Fayez Sarofim & Co fully exited Brookfield in Q1 2025, selling an estimated $1.16M.
  • Fayez Sarofim & Co's ten largest holdings make up 41% of its $40.2B portfolio in Q1 2025.
  • Fayez Sarofim & Co opened 14 new positions and closed 15 in Q1 2025.
  • Fayez Sarofim & Co's portfolio value fell 2.3% quarter-over-quarter to $40.2B.

Based on Fayez Sarofim & Co's 13F filing for Q1 2025, filed 12 May 2025.